European Archives - Page 318 of 1156 - European Medical Journal

Precision Genomic Testing Improves Survival in Paediatric Oncology

New research shows that integrating precision genomic testing with targeted therapies improves treatment responses and progression-free survival in pediatric oncology.

Algorithm-Based Referrals Enhance Palliative Care Access

An algorithm-based default referrals system has led to a fourfold increase in the use of specialty palliative care within a large community oncology network.

Prostate Cancer Treatment Linked to Increased Cardiovascular Risk

Significant cardiovascular risks associated with adding androgen receptor signalling inhibitors to standard androgen deprivation therapy in patients with advanced prostate cancer.

Ipsen Symposium at ESPGHAN 2024: PFIC Through a Different Lens: How Can You Change the Course of the Disease?

This video presents the satellite symposium hosted by Ipsen at the 56th Annual Meeting of the European Society for Paediatric…

Improved Prostate Cancer Diagnosis with AI

New research has shown that an AI system can more efficiently detect clinically significant prostate cancer on MRI compared to radiologists.

Acalabrutinib and Chemotherapy Enhance Survival in Mantle Cell Lymphoma

Frontline treatment with acalabrutinib, bendamustine, and rituximab shows promising results in reducing disease progression and death in older mantle cell lymphoma patients.

TP53 Mutations: Key to CLL Progression and Treatment

Study reveals the significant impact of TP53 mutations on chronic lymphocytic leukaemia progression and survival, emphasising the importance of mutation type and treatment strategy

Vitamin C Associated with Improved Survival in Low-Risk Myeloid Malignancies

Results from a trial on the use of vitamin C supplementation for the treatment of low-risk myeloid malignancies were presented at the 2024 European Haematology Association Congress

Primary Ovarian Insufficiency Increases Risk for Reproductive Cancers

Females with primary ovarian insufficiency, experiencing menopause at ≤40 years, face a heightened risk for breast cancer, and ovarian cancer, according to new research.

Positron Emission Tomography Reliably Predicts Dementia Progression

Recent data demonstrated that tau positron emission tomography has significant prognostic value in predicting the progression from mild cognitive impairment to dementia.